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Ewing sarcoma (ES) is the second most frequent primary malignant bone cancer, following ostteosarcoma. The frequency of ES in the poput
lation younger than 20 years is approximately 2.9 per 
million.1 It is slightly more common in males.2 ES is a 
small roundtcell tumor typically arising in the bones, 
and rarely in soft tissues, of children and adolescents.3 
We describe 4 children diagnosed with ES who were 
encountered in our clinical practice within a period of 
one year (2008t2009).
CASE 1
A 3tyeartold male child complained of limbing and 
bone aches in the left lower limb for about 6 months. It 
was misdiagnosed initially as rheumatoid arthritis and 
he was given nonsteroidal antitinflammatory drug treatt
ment with partial improvement of pain. Four months 
later, during a trivial trauma while playing, a fracture 
developed at the lower third of the left femur, which 
was visible by xtray (Figure 1a). He was immobilized in 
a cast for about 2 months. 
There was a progressive enlargement of the whole 
left femur. Xtray of the left femur revealed two osteot
lytic masses that occupied the upper and lower third 
of the left femur with periosteal reaction (Figure 1b). 
CT of the left femur revealed two large expansile ost
The many faces of Ewing sarcoma: difficult to 
diagnose pediatric cases
Asharf Fouda, Ahmed Mansour, Youssef AltTonbary
mansoura university children’s hospital, 35516, faculty of medicine, mansoura university al-mansoura, egypt
correspondence: asharf fouda mansoura · university children’s hospital, 35516, faculty of medicine, mansoura university al-mansoura, egypt 
· ashraf_foda@mans.edu.eg
hematol oncol stem cell ther 2009; 2(3): 411-417
ewing sarcoma (es) is the second most frequent primary malignant bone cancer, following osteosarcoma. 
es is a small round-cell tumor typically arising in the bones, rarely in soft tissues, of children and ado-
lescents. We describe four children aged 3, 3.5, 9, and 9.5 years, who presented with two femur masses 
simultaneously (patient 1), a huge mediastinal mass (patient 2), an abdomino-mediastinal mass with 
dysphagia (patient 3), and a huge abdomino-pelvic mass (patient 4). our patients were of younger age 
and had abnormal presentations that made initial diagnosis difficult, but also are representative of the 
different problems encountered in pediatric practice. biopsy initially revealed round cell tumor and by 
immunohistochemistry, cd99 was positive, which confirmed the diagnosis of es. our patients were dif-
ficult to diagnosis.the patients were misdiagnosed initially, so there was a delay in diagnosis. definitive 
diagnosis required use of various radiological imaging methods and immunohistochemistry.
teolytic lesions affecting the upper and lower thirds of 
the left femoral shaft (Figure 1c). Biopsy obtained from 
the masses revealed infiltration by malignant round cell 
tumor (Figure 1d, 1e). CD 99 was positive (Figure 1f ). 
Amputation of the left lower limb by disarticulat
tion was done and the patient received chemotherapy 
(vincristine 2 mg/m2 day 1, Adriamycin 35 mg/m2/day 
days 1t2 and cyclophosphamide 900 mg/m2/day days 
1t2 plus mesna IV infusion alternating every 3 weeks 
with etoposide 100 mg/m2/day days 1t5 and ifosfamide 
1800 mg/m2/day days 1t5 plus mesna IV infusion for 
total treatment of 51 weeks). The patient died after 3 
month of starting treatment as he developed febrile 
neutropenia (total leucocytic count was about 300 cell/
cm3) and he suffered from extensive Klebsiella pneuv
moniae bronchopneumonia. 
CASE 2
A 9.5tyeartold female child complained of difficult 
breathing, dry cough with no expectoration, swelling of 
the left chest wall, anorexia, weight loss and fever. There 
was no history of trauma to the chest nor chest disease 
in the family. She was misdiagnosed as having lefttsided 
pneumonia and was treated as an outpatient with an ant
tibiotic for 2 weeks without improvement. At presentat
tion, she was fully conscious and appeared ill. Her weight 
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and height were below the 10th and 50th percentile ret
spectively. The respiratory rate was 40/min with subt
costal and intercostal retractions. The heart rate was 
110/min regular. Congested pulsating neck veins were 
visible on the right neck side while they were congested 
and nonpulsating on the left side. There was pallor, no 
cyanosis, no jaundice and no clubbing. The left axillary 
lymph nodes were palpable (0.5×1 cm, firm, mobile 
and not tender). The trachea was shifted to the right 
side. There was a chest wall mass anteriorly opposite to 
the 4th left rib (2×3 cm, hard, fixed to skin and chest 
wall, and nontender). There was limited expansion of 
the left side of the chest with multiple pulsations at the 
right 4th, 5th and 6th spaces. A dull note of percussion 
over left side of the chest was noticed with diminished 
breath sounds. Heart sounds were heard over the right 
side of the chest anteriorly.
Laboratory tests were as follows: hemoglobin 
10.2 g/dL, WBCs 16×109/L, platelets 569×109/L, 
ESR=35/72mm/hour (1st/2nd hour), LDH=2078U/
L, CRP=50mg/dL, serum creatinine=0.5mg/dL and 
blood culture was negative.
A chest xtray showed lefttsided homogenous opact
ity and shift of the heart and mediastinum to the right 
side, suggesting a massive lefttside pleural effusion 
(Figure 2a). A trial aspiration was done but failed (no 
fluid was aspirated). CT of the chest revealed a large 
heterogenous mass at the left pleural cavity, and det
struction of the anterior aspect of the 4th rib (Figure 
2b). A bone scan using 740MBq of 99mTctMDP 
gamma camera examination revealed an abnormal int
crease in bone activity at the 4th to 12th lefttsided ribs 
suggesting a neoplastic process (Figure 2c). A Trutcut 
biopsy from the left chest mass revealed a malignant 
round cell tumor. CD99 was moderately positive and 
leukocyte common antigen (LCA) and desmin were 
negative. The patient was referred to the pediatric ont
cology unit to receive specific treatment chemotherapy 
Figure 1a. X-ray of left femur showing a 
pathological fracture between middle and 
lower third femur. also there is osteolytic 
lesion at upper third of the femur. 
Figure 1b. X-ray of left femur showing 
two osteolytic masses occupied upper 
and lower third of the left femur with 
periosteal reaction
Figure 1c. CT of the left femur showing 
two large expansile osteolytic lesions 
affecting upper and lower thirds of the left 
femoral shaft, associated with periosteal 
reaction, cortical destruction and small 
extra osseous soft tissue encasing the 
related neurovascular bundles. There 
was no detected intra-articular extension 
with normal both hip and knee joints and 
no detected synovial effusion.
Figure 1d and 1e. Hematoxylin and eosin stain of the biopsy showing a malignant round 
cell tumor (small atypical cells, with large hyperchromatic nuclei, prominent nucleoli, 
mitotic figures). (Figure 1d magnification ×40,1e magnification ×100). 
Figure 1f. immunohistochemistry stain of 
biopsy showing a positive Cd 99.
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Figure 2a. Chest x-ray showed left-sided homogenous opacity, 
and shift of the heart and mediastinum to the right side.
Figure 2b. CT chest showing a large heterogenous mass at 
left pleural cavity, and destruction of anterior aspect of 4th rib 
with an extrathoracic soft tissue component, displacing the 
descending aorta to the right side. There was evidence of left 
lung collapse and right mediastinal shift. 
Figure 2c. Bone scan using 740MBq of 
99mTc-MdP gamma camera examination 
reveals abnormal increase in bone 
activity at 4th to 12th left sided ribs.
(the same as that described for patient 1) and radiot
therapy. She was still alive after 6 months of treatment 
and there was a marked reduction of the tumor mass 
with serial xtrays. 
CASE 3
A 9tyeartold male child presented with fever, loss of 
weight, and easy fatigability. There had been dysphagia 
to fluids and solid food for about 40 days. At present
tation, he appeared ill, his weight was below the 10th 
percentile and his height was within the 50th percent
tile. There was no history of caustic ingestion or previt
ous diseases. There was pallor with no jaundice. There 
was no lymph node enlargement, no abdominal masses, 
and no bleeding tendency. Diminished breath sounds 
were noticed over the left posterior lung base.
A chest xtray revealed left pleural effusion with 
right mediastinal shift (Figure 3a). In the evaluation 
of dysphagia, a barium swallow revealed a stenosed 
lower esophagus with proximal dilation and a normal 
mucosal pattern (Figure 3b). CT chest revealed a large 
welltdefined mass in the paravertebral area, which was 
thought to be a neuroblastoma (Figure 3c). A bone 
survey was normal with no bony masses. Bone mart
row aspiration was normal. Biopsy from the mass was 
diagnosed as malignant round cell tumor (Figure 3d, 
3e). CD99 was a positive membranous reaction with 
negative LCA and synaptophysin (Figure 3f ).
The patient received chemotherapy and radiothert
apy. He was also maintained on total parental nutrit
tion for about 2 weeks until the dysphagia improved. 
He was still alive after 3 months of treatment with a 
marked reduction of the chest mass.
CASE 4
A 3.5tyeartold female child had complained of lowt
grade intermittent fever not responsive to antibiott
ics for about 1.5 months. There had been progressive 
abdominal enlargement and weight loss for the last 2 
weeks. At presentation, there was no jaundice, no purt
pura or ecchymosis, and no lymphadenopathy. Her 
body weight was below the 5th percentile while height 
was within the 50th percentile. Abdominal examinat
tion revealed a distended abdomen with a huge mass 
palpable at the left hypochondrium (10×15 cm, hard, 
fixed and nontender) with a normal liver span of about 
10 cm.
The CBC was normal, ESR was high 84/120 mm 
(1st /2nd h), serum albumin=3.5/dL, ALT=15 U/L, 
serum bilirubin=0.6 mg/dL, serum creatinin=0.5mg/
dL. Ultrasonography showed a large left hypochont
drial mass markedly displacing the spleen superiorly 
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Figure 3a. Chest x-ray showing a left pleural effusion with right 
mediastinal shift.
Figure 3b. Barium swallow showing a stenosed lower esophagus 
with proximal dilation and normal mucosal pattern.
Figure 3c. CT chest revealed a large well-defined lobulated mass 
(17×10×15cm) in the paravertebral area more to the left side 
extending upward to a tracheal bifurcation and downward to the 
level of the upper pole of left kidney with minimal hetrogenicity. 
There was no calcification nor cystic degeneration, and no 
evidence of bony infiltration of the ribs or vertebrae. The 
mass is seen surrounding the aorta, displacing the heart and 
compressing the inferior vena cava and the esophagus with no 
air inside.
Figure 3d and 3e. 
Hematoxylin and 
eosin stain of the 
biopsy shows 
malignant round cell 
tumor (small atypical 
cells, with large 
hyperchromatic 
nuclei, prominent 
nucleoli, mitotic 
figures) (Figure 3d 
magnification ×40, 3e 
magnification ×100). 
without splenic infiltrations. CT of the abdomen and 
pelvis revealed a large oval abdominotpelvic mass at the 
left hypochondrium (Figure 4a). There was no bony 
metastasis confirmed by 99mTCtMDp gamma camera 
(Figure 4b). Biopsy revealed undifferentiated round 
cell tumor cells and CD99 was positive with negative 
LCA, desmin and synaptophysin.
The patient received chemotherapy and serial folt
lowtup ultrasound showed a marked reduction of the 
tumor mass to 8×7×6 cm after 1 month of chemot
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Figure 3f. immunohistochemistry stain of biopsy shows a positive 
Cd 99. 
Figure 4a. CT abdomen and pelvis shows a large oval pelvi-
abdominal mass (10×12.5×10 cm) occupying left hypochondrium 
displacing spleen upward and left kidney downward without 
bony infiltration.
Figure 4b. 99mTC-Mdp gamma camera 
bone scan showing no bony metastasis.
therapy. The mass was surgically removed and the pat
tient received radiotherapy. She was still alive after 10 
months of treatment. 
DISCuSSION
The Ewing family of tumors includes classic ES, atypit
cal ES, primitive neuroectodermal tumor (PNET), and 
Askin tumor. Ewing tumors are derived from postgant
glionic parasympathetic primordial cells and can occur 
in any part of the body.4 ES is the second most common 
malignant bone tumor in children and develops most 
often in the long bones and pelvis, but may arise in any 
bone. Up to 6.5% of tumors will occur primarily in the 
chest wall, making it the most frequent chest wall tut
mor.5 ES usually presents in the second decade of life 
and has a male predominance of approximately 1.6:1 
and a predilection for whites.4 ES has a predilection 
for the male sex (male/female ratio, 1.3t1.5:1). ES oct
curs in a wide range of ages from infants to the elderly, 
although approximately 80% of patients afflicted are 
younger than 20 years of age. Peak incidence is during 
the second decade of life, although 20% to 30% of cases 
are diagnosed in the first decade. The age of the patient 
is important diagnostically. When confronted with pat
tients older than 30 years, the clinician must first elimit
nate other small roundtcell tumors, including smalltcell 
carcinoma and largetcell lymphoma, before making a 
diagnosis of ES. In patients younger than 5 years, the 
possibility of metastatic neuroblastoma or acute leuket
mia needs to be ruled out.3 In children, incidence rates 
of 2.9 per million for Ewing tumors presenting as bone 
tumors were reported.1
The cause and cell origin of ES are unknown; howt
ever, it has been suggested that neural tissue may be the 
common origin of ES. There has been a chromosomal 
translocation t(11;22) described, suggesting the possit
bility of oncogene formation.6 Reciprocal chromosomal 
translocation between chromosomes 11 and 22, the 
t(11;22)(q24;q12), is present in about 85% of these 
tumors, and is therefore considered pathognomonic 
for the disease. Using molecular detection methods, the 
presence of the t(11;22)(q24;q12) has been confirmed 
and found to correlate with high expression of the cell 
surface sialoglycoprotein CD99MIC2.2
ES primarily occurs in bones, with rare occurrences 
in soft tissues. Most extratskeletal ESs affect patients 
between 10 and 30 years of age, with a peak incidence 
at approximately 20 years old. The most common sites 
are the chest wall, paravertebral muscles, extremities, 
buttocks and retrotperitoneal space. Extratskeletal ES 
present with rapid growth and frequent distant metast
tases, similar to ES of bone.3
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ES that arises from the soft tissues and spares the 
skeletal bones has been identified as a much less comt
mon and distinct entity, namely an extraskeletal ES.7 
The first large series (39 cases) of extraosseous ES was 
published by Angervall and Enzinger8 in 1975, of which 
12 patients had the tumor in the paravertebral region, 
mainly at the lumbar and sacral level. Subsequently, it 
had been shown to occur at various sites in the human 
body including the soft tissues of the orbit, vagina, kidt
ney and the posterior mediastinum.8t13 
The classical histopathologic description of an ext
traskeletal ES is small with round blue cells that are 
uniform in appearance and organized in solid sheets 
that are divided by fibrous strands. An extraskeletal 
ES shares histopathologic and immunohistochemical 
findings with ES and thus may be confused with emt
bryonal rhabdomyosarcoma, lymphoma, and neurot
blastoma.14 Therefore, confirmation of the diagnosis of 
an extraskeletal ES should rely on positive staining for 
CD99 on immunohistochemical analysis.15
ES most commonly involves the lower extremity, 
with the pelvis being the next most common site. In 
long bones, ES usually begins in the diaphysis.16 Our 
first patient presented with 2 masses at the femur that 
initially presented with pathological fracture. When a 
child has a fracture after minimal trauma or when the 
radiographs suggest an abnormal process in the bone 
or an inappropriate site or pattern for the fracture, 
pathologic fracture should be suspected.17 Groups of 
pathologic entities that can result in pathologic fract
ture include genetic or metabolic bone disease abnort
malities (e.g., osteogenesis imperfecta or osteopetrosis), 
nutritional or environmental disturbances (e.g., rickt
ets), benign bone tumors (e.g., cysts, cartilage, fibrous 
tumors), skeletal sarcomas (e.g., osteosarcoma, Ewing 
sarcoma), and skeletal metastases (e.g., neuroblastoma, 
rhabdomyosarcoma).18 After clinical radiological and 
laboratory evaluation, potentially benign aggressive or 
malignant processes should be biopsied (biopsy must 
be done through a small longitudinal easily excised int
cision, through a single compartment, with meticulous 
hemostasis).18 
Of all pediatric mediastinal masses, 30% to 40% oct
cur in the posterior mediastinum. Most of these masses 
(85%t90%) are of neurogenic origin. Imaging, particut
larly CT and MR imaging, is used as a guide for det
termining extent of disease, establishing a differential 
diagnosis list, and help in judging the efficacy of treatt
ment.19 
Neurogenic tumors fall into three categories: gant
glion cell tumors, nerve sheath and nerve tumors, and 
other nervous tissue tumors, such a paragangliomas. 
The other, less common posterior mediastinal masses 
include extramedullary hematopoiesis, lipomatosis, 
vascular masses, including hemangiomas and vascular 
malformations and soft tissue malignancies, such as 
ES, germ cell tumors, and rhabdomyosarcoma.19 The 
differential diagnosis of a mediastinal mass can be est
tablished by examining the location of the lesion and 
its appearance on radiographic studies. The diagnosis 
is further narrowed by considering the patient’s age, 
sex, clinical symptomatology, and in certain cases, the 
results of finetneedle aspiration cytologic studies. Most 
posterior mediastinal masses in young adults represent 
tumors of nerve cell origin. ES was reported in a young 
patient with intraspinal extension presenting as a post
terior mediastinal mass.8
Any abdominal mass in a child must be considered 
malignant until diagnostic imaging and laboratory findt
ings define its true nature. If there is any doubt, biopsy 
or excision and histological verification is the final arbit
ter. The differential diagnosis of malignant abdominal 
and pelvic tumors includes Wilms tumor, neuroblast
toma, nontHodgkin tumor, rhabdomyosarcoma, germ 
cell tumor/teratoma, hepatoblastoma and hepatoma.20 
ES presenting as an abdominal mass is a rare presentat
tion. It has been reported as a renal mass21,22 or a retrot
peritoneal mass.23 Our fourth patient presented with a 
huge abdominopelvic mass with no bony involvement 
confirmed by gamma camera scanning.
ES has retained the most unfavorable prognosis of 
all primary musculoskeletal tumors. Prior to the use of 
multitdrug chemotherapy, longtterm survival was less 
than 10%. The development of multidisciplinary thert
apy with chemotherapy, irradiation, and surgery has int
creased current longtterm survival rates in most clinical 
centers to greater than 50%. In addition, the preferred 
method of tumor resection has changed; limb salvage has 
nearly replaced amputation of the affected limb. Limb 
salvage procedures can be performed in place of amputat
tion without compromising patient survival rates.3
Although an extraskeletal ES often presents as a lot
cal disease, it should be regarded as a systemic, yet curt
able disease. Hence, an aggressive multimodal managet
ment strategy should be undertaken.24 Surgery should 
initially be performed in an attempt to attain wide ret
section margins, and radiation therapy should be used 
as an adjunct to resection in an attempt to improve cont
trol of the obvious local disease, whereas chemotherapy 
should also be incorporated in an attempt to address 
the obscure systemic disease.25
Ewing tumors of the chest wall should be treated 
like Ewing tumors elsewhere. All should receive chemot
therapy before surgery to achieve in a higher number 
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of patients local control, to have less extensive surgery, 
and to treat distant microscopic metastatic lesions.4 
Related to late effects of radiotherapy, that is, lung 
damage, increased cardiac toxicity related to the use of 
anthracyclines, chest wall deformities, and secondary 
malignancies, a reduction of the number of patients 
needing irradiation should be only considered in wellt
defined cases. Chemotherapy formerly consisted of a 
combination of vincristine, actinomycintD, and cyclot
phosphamide. Nowadays doxorubicin is added in most 
protocols. Other drugs used in the majority of patients 
are ifosfamide and etoposide.4
In conclusion, we have described four children diagt
nosed as having ES. Our patients were similar in being 
of a younger age and represent abnormal rare present
tations. Biopsy initially revealed round cell tumor that 
by immunohistochemistry were CD99 positive, which 
confirmed the diagnosis of ES. Our patients were dift
ficult to diagnosis. There was delay in discovery, mist
diagnosed initially, and diagnosis required a multidiscit
plinary approach: different radiological imaging metht
ods and a immunohistochemistry to reach a definite 
diagnosis. ES should be considered in any pathological 
fracture and should be included in the differential diagt
nosis of any malignant round cell tumor of the mediastit
num or the abdomen.
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